TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 26 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $100,731,000 | +81.0% | 5,736,363 | 0.0% | 1.20% | +65.1% |
| Q2 2021 | $55,643,000 | -9.7% | 5,736,363 | 0.0% | 0.72% | -47.6% |
| Q1 2021 | $61,609,000 | -27.0% | 5,736,363 | 0.0% | 1.38% | -37.9% |
| Q4 2020 | $84,382,000 | +3.5% | 5,736,363 | 0.0% | 2.23% | -35.4% |
| Q3 2020 | $81,514,000 | +75.7% | 5,736,363 | 0.0% | 3.45% | +84.9% |
| Q2 2020 | $46,407,000 | +100.2% | 5,736,363 | 0.0% | 1.87% | +54.1% |
| Q1 2020 | $23,175,000 | +971.4% | 5,736,363 | +173.2% | 1.21% | +1087.3% |
| Q4 2019 | $2,163,000 | +234.8% | 2,100,000 | 0.0% | 0.10% | +92.5% |
| Q3 2019 | $646,000 | -6.5% | 2,100,000 | 0.0% | 0.05% | +10.4% |
| Q2 2019 | $691,000 | -50.1% | 2,100,000 | 0.0% | 0.05% | -33.3% |
| Q1 2019 | $1,386,000 | -35.2% | 2,100,000 | +68.0% | 0.07% | -15.3% |
| Q4 2018 | $2,138,000 | -70.5% | 1,250,000 | 0.0% | 0.08% | -72.8% |
| Q3 2018 | $7,250,000 | -3.3% | 1,250,000 | 0.0% | 0.31% | -10.8% |
| Q2 2018 | $7,500,000 | -16.7% | 1,250,000 | 0.0% | 0.35% | -12.2% |
| Q1 2018 | $9,000,000 | -0.7% | 1,250,000 | 0.0% | 0.40% | +6.7% |
| Q4 2017 | $9,063,000 | +67.6% | 1,250,000 | +19.0% | 0.38% | +98.4% |
| Q3 2017 | $5,408,000 | +17.1% | 1,050,000 | 0.0% | 0.19% | +12.5% |
| Q2 2017 | $4,619,000 | – | 1,050,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|